Ever wonder why we’re called StarFish? Check out Scott’s video for the key “points” in our October Newsletter.
- Paul Cataford, Zephyr Sleep Technologies CEO, talks about the North American roll-out of MATRx™ – the company’s Medical Device for determining whether oral appliance therapy will treat Obstructive Sleep Apnea
- FDA impacted by US Budget shutdown
- StarFish Medical’s Director of Quality/Regulatory, Vesna Janic comments on recent FDA Guidances
- Vincent Crabtree provides insight on: FDA issues final guidance on mobile medical apps, New rapid blood test can differentiate between bacterial and viral infections, and Phonebloks: The smartphone for the rest of your life.